ONCOLYTICS BIOTECH INC (ONC.CA) Stock Balance Sheet
TSX:ONC - Toronto Stock Exchange - CA6823108759 - Common Stock - Currency: CAD
| MRQ (2024-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.23M | 11.67M | 1.36M | 860.00K | 1.09M | |||
| Marketable Securities | 15.46M | 20.47M | 39.90M | 30.36M | 13.06M | |||
| Receivables | 104.00K | 520.00K | 870.00K | 90.00K | 2.07M | |||
| Other Current Assets | 2.12M | 3.03M | 2.78M | 2.43M | 2.71M | |||
| Total Current Assets | 22.91M | 35.68M | 44.90M | 33.74M | 18.93M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.35M | 650.00K | 980.00K | 610.00K | 730.00K | |||
| Other Non-Current Assets | N/A | 1.00M | N/A | N/A | N/A | |||
| Total Non-Current Assets | 1.35M | 1.65M | 980.00K | 610.00K | 730.00K | |||
| TOTAL ASSETS | 24.26M | 37.33M | 45.88M | 34.35M | 19.66M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 251.00K | 220.00K | 290.00K | 250.00K | 340.00K | |||
| Accrued Expenses | 3.50M | N/A | N/A | N/A | N/A | |||
| Accounts Payable | 3.43M | 3.65M | 1.99M | 1.81M | 3.17M | |||
| Other Current Liabilities | 489.00K | 80.00K | 410.00K | 660.00K | 9.36M | |||
| Total Current Liabilities | 7.66M | 3.95M | 2.69M | 2.71M | 12.87M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 813.00K | 160.00K | 360.00K | 150.00K | 170.00K | |||
| Other Non-Current Liabilities | 6.73M | 6.73M | 6.73M | 6.73M | 6.73M | |||
| Total Non-Current Liabilities | 7.54M | 6.88M | 7.09M | 6.88M | 6.90M | |||
| TOTAL LIABILITIES | 15.21M | 10.83M | 9.78M | 9.59M | 19.77M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -469.70M | -418.25M | -393.42M | -367.11M | -344.61M | |||
| Additional Paid In Capital | 43.64M | 40.05M | 37.78M | 34.64M | 32.96M | |||
| Common Shares | 434.46M | 404.04M | 391.35M | 356.82M | 311.08M | |||
| Other Shareholders' Equity | 653.00K | 660.00K | 390.00K | 400.00K | 460.00K | |||
| Shares Outstanding | 77.07M | 61.33M | 55.04M | 46.17M | 32.20M | |||
| Tangible Book Value per Share | 0.12 | 0.43 | 0.66 | 0.54 | -0.00 | |||
| Total Shareholders' Equity | 9.06M | 26.50M | 36.10M | 24.75M | -110.00K | |||
| TOTAL LIABILITIES AND EQUITY | 24.26M | 37.33M | 45.88M | 34.35M | 19.66M | |||
| Statistics | ||||||||
| Debt/Equity | 0.09 | 0.01 | 0.01 | 0.01 | -1.55 | |||
| Current Ratio | 2.99 | 9.03 | 16.69 | 12.45 | 1.47 | |||
| Return On Assets (ROA) | -113.93% | -66.54% | -57.32% | -65.53% | -168.46% | |||
| Return On Equity (ROE) | -305.20% | -93.74% | -72.85% | -90.95% | N/A | |||
All data in CAD , ROIC based on taxRate of 0.25